| Gene symbol | PMEL | Synonyms | D12S53E, HMB-45, HMB45, ME20, ME20-M, ME20M, P1, P100, PMEL17, SI, SIL, SILV, gp100 | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12q13.2 | dbXrefs | |
| Description | premelanosome protein | ||||
| GTO ID | GTC1368 |
| Trial ID | NCT01211262 |
| Disease | Malignant Adenoma |
| Altered gene | gp100 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | gp100 TCR-T cells |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase 1, Open Label, Dose Finding Study to Assess the Safety and Tolerability of IMCgp100, a Monoclonal T Cell Receptor Anti-CD3 scFv Fusion Protein in Patients With Advanced Malignant Melanoma |
| Year | 2010 |
| Country | United States |
| Company sponsor | Immunocore Ltd |
| Other ID(s) | IMCgp100/01|2010-019290-15 |
| Cohort 1 | |||||||||
|
|||||||||